The following pages link to Stuart G. Baker (Q2827193):
Displayed 26 items.
- The latent class twin method (Q2827194) (← links)
- Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time (Q2894011) (← links)
- (Q3008893) (← links)
- Compliance Subsampling Designs for Comparative Research: Estimation and Optimal Planning (Q3078837) (← links)
- Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial (Q3303554) (← links)
- Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates (Q3434119) (← links)
- A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint (Q3434121) (← links)
- Regression Analysis of Grouped Survival Data: Informative Censoring and Double Sampling (Q4274319) (← links)
- Marginal Regression for Repeated Binary Data with Outcome Subject to Non- Ignorable Non-Response (Q4335730) (← links)
- The Analysis of Categorical Case-Control Data Subject to Nonignorable Nonresponse (Q4349016) (← links)
- A Proposed Design and Analysis for Comparing Digital and Analog Mammography (Q4419432) (← links)
- Correction to “Genetic Susceptibility to Prostate, Breast and Colorectal Cancer among Nordic Twins,” by Stuart G. Baker, Paul Lichtenstein, Jaakko Kaprio and Niels Holm; 61, 55–63, December 2005 (Q4649082) (← links)
- Evaluating the Age to Begin Periodic Breast Cancer Screening Using Data from a Few Regularly Scheduled Screenings (Q4666099) (← links)
- Identifying Combinations of Cancer Markers for Further Study as Triggers of Early Intervention (Q4670461) (← links)
- Regression Analysis of Grouped Survival Data with Incomplete Covariates: Nonignorable Missing-Data and Censoring Mechanisms (Q4842875) (← links)
- A Score Test for Non-Informative Censoring Using Doubly Sampled Grouped Survival Data (Q4844087) (← links)
- Evaluating Multiple Diagnostic Tests with Partial Verification (Q4844332) (← links)
- Letter to the Editor: “Comment on Hubbard and Miglioretti (2013), Consider Also a Selection Model for the Cumulative Risk of False Positive Screening Tests” (Q5408032) (← links)
- Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis (Q5424960) (← links)
- Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis (Q5442624) (← links)
- A Simple Loglinear Model for Haplotype Effects in a Case-Control Study Involving Two Unphased Genotypes (Q5700514) (← links)
- Rethinking historical controls (Q5701113) (← links)
- A sensitivity analysis for nonrandomly missing categorical data arising from a national health disability survey (Q5701176) (← links)
- Genetic Susceptibility to Prostate, Breast, and Colorectal Cancer among Nordic Twins (Q5715352) (← links)
- Statistics for Weighing Benefits and Harms in a Proposed Genetic Substudy of a Randomized Cancer Prevention Trial (Q5757807) (← links)
- Estimating Efficacy in a Proposed Randomized Trial With Initial and Later Non-Compliance (Q5757868) (← links)
